Niacinamide

poly(ADP-ribose) polymerase 1 ; Homo sapiens







111 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33801950 Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins. 2021 Mar 10 1
2 34587882 Poly(ADP-Ribose) Polymerase-1 Inhibitors Drug Discovery, Design, and Development as Anticancer Agents from Past to Present: A Mini-Review. 2021 Sep 29 2
3 34845199 Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells. 2021 Nov 29 1
4 32788029 [Progress of nicotinamide in preventing infection and sepsis]. 2020 Jul 2
5 32903806 Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer's Disease. 2020 7
6 30912451 Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib. 2019 May 3
7 31257855 Quartz Crystal Microbalance Detection of Poly(ADP-ribose) Polymerase-1 Based on Gold Nanorods Signal Amplification. 2019 Sep 3 1
8 31308445 Nicotinamide Augments the Anti-Inflammatory Properties of Resveratrol through PARP1 Activation. 2019 Jul 15 3
9 29968072 Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. 2018 Dec 1
10 27990620 Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions. 2017 Oct 2
11 28695516 Strategies Employed for the Development of PARP Inhibitors. 2017 2
12 26518726 Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide Bioisosteres. 2016 Mar 4
13 26709902 Alternative mechanisms of inhibiting activity of poly (ADP-ribose) polymerase-1. 2016 Jan 1 2
14 27193581 Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity. 2016 Aug 1
15 25504347 Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin. 2015 Feb 1
16 26387143 Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. 2015 Dec 2
17 26788021 Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP). 2015 Oct 2
18 24635573 Nicotinamide and the skin. 2014 Aug 2
19 24641686 Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets. 2014 Apr 9 1
20 24993939 Niacinamide - mechanisms of action and its topical use in dermatology. 2014 2
21 23290998 Poly(ADP-ribose): PARadigms and PARadoxes. 2013 Dec 1
22 23454167 NAD(+) influx through connexin hemichannels prevents poly(ADP-ribose) polymerase-mediated astrocyte death. 2013 Apr 19 1
23 23879431 Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases. 2013 Sep 12 1
24 22204321 NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases. 2012 Feb 1
25 22233320 Structural basis of selective inhibition of human tankyrases. 2012 Feb 9 1
26 22293058 Intrinsic radiation resistance of mesenchymal cancer stem cells and implications for treatment response in a murine sarcoma model. 2012 Feb 1
27 22297980 Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939. 2012 Feb 1 1
28 22365563 Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors. 2012 Apr 1
29 22465780 Nicotinamide treatment reduces the levels of histone H3K4 trimethylation in the promoter of the mper1 circadian clock gene and blocks the ability of dexamethasone to induce the acute response. 2012 Aug 1
30 22476980 Natural inhibitors of poly(ADP-ribose) polymerase-1. 2012 Aug 1
31 21825006 Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft. 2011 Oct 1
32 21870251 Approaches to detect PARP-1 activation in vivo, in situ, and in vitro. 2011 1
33 21870278 Strategies employed for the development of PARP inhibitors. 2011 2
34 20005237 Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. 2010 Mar 1
35 20633699 Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. 2010 Sep-Oct 1
36 20725615 Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. 2010 Jul 25 2
37 20804590 Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide. 2010 Aug 24 1
38 19127080 Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells. 2009 1
39 18199640 Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. 2008 Mar 1
40 18230337 p53-, SIRT1-, and PARP-1-independent downregulation of p21WAF1 expression in nicotinamide-treated cells. 2008 Apr 4 2
41 18600553 Cytoprotective effects of nicotinamide derivatives in endothelial cells. 2008 Jun 2
42 17504138 Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation. 2007 1
43 17520094 Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update. 2007 Apr 2
44 16505238 MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells. 2006 Mar 1
45 16604373 Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure. 2006 Jun 3
46 16611073 Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. 2006 1
47 16631419 Binding mode of novel 1-substituted quinazoline derivatives to poly(ADP-ribose) polymerase-catalytic domain, revealed by X-ray crystal structure analysis of complexes. 2006 May 1
48 17384246 Molecular determinants involved in the increase of damage-induced apoptosis and delay of secondary necrosis due to inhibition of mono(ADP-ribosyl)ation. 2006 Dec 1
49 20021043 Nicotinamide prevents apoptosis in human cortical neuronal cells. 2006 2
50 15857303 Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. 2005 Apr 2